SIR 2025

Should IO + Immunotherapy be the standard of care for intermediate and advanced HCC in 2025? (IO + immunotherapy

Speaker(s)

• 

  Laura Crocetti, MD, PhD (she/her/hers)

  Associate Professor
  Università di Pisa, Italy
• 

  Shamar Young, MD

  Professor
  University of Arizona, United States